Managers / Q3 2022 · view latest →
HIGHLINE CAPITAL MANAGEMENT, L.P.
CIK 0001166850 · 10 EAST 53RD STREET, 11TH FLOOR, NEW YORK, NY, 10022 · 2123322250
Summary
Highline Capital Management, L.P. reported $54M in U.S.-listed holdings across 15 positions for Q3 2022.
Its largest position, UNH, represents 17.4% of the portfolio.
Compared with Q2 2022, the fund opened 5 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 77.7% · $42M
- Other · 9.3% · $5M
- ADR · 8.8% · $5M
- NY Reg Shrs · 3.5% · $2M
- Equity WRT · 0.7% · $390,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BWXTBWX TECHNOLOGIES INC | NEW | +99.5K | 99.5K | +$5M | $5M |
| GTNGRAY TELEVISION INC | NEW | +348.7K | 348.7K | +$5M | $5M |
| MSFTMICROSOFT CORP | NEW | +20.7K | 20.7K | +$5M | $5M |
| FOCLEDAP TMS S A | NEW | +333.3K | 333.3K | +$3M | $3M |
| TAKTAKEDA PHARMACEUTICAL CO LTD | NEW | +150.0K | 150.0K | +$2M | $2M |
| XOPSPDR SER TR | SOLD OUT | −43.7K | 0 | −$5M | $0 |
| CFCF INDS HLDGS INC | SOLD OUT | −20.6K | 0 | −$2M | $0 |
| BABAALIBABA GROUP HLDG LTD | SOLD OUT | −7.8K | 0 | −$882,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | UNHUNITEDHEALTH GROUP INChistory → | COM | 17.43% | $9M | 18.5K |
| 2 | ASTLALGOMA STL GROUP INC | COM · *W EXP 10/19/202 | 10.47% | $6M | 1.22M |
| 3 | AMZNAMAZON COM INChistory → | COM | 9.51% | $5M | 45.0K |
| 4 | BWXTBWX TECHNOLOGIES INChistory → | COM | 9.37% | $5M | 99.5K |
| 5 | GTNGRAY TELEVISION INChistory → | COM | 9.33% | $5M | 348.7K |
| 6 | MSFTMICROSOFT CORPhistory → | COM | 9.01% | $5M | 20.7K |
| 7 | MOSMOSAIC CO NEWhistory → | COM | 6.87% | $4M | 76.0K |
| 8 | AVTRAVANTOR INChistory → | COM | 6.41% | $3M | 175.1K |
| 9 | FOCLEDAP TMS S Ahistory → | SPONSORED ADR | 5.14% | $3M | 333.3K |
| 10 | MARKETWISE INC | COM CL A | 4.52% | $2M | 1.06M |
| 11 | MTARCELORMITTAL SA LUXEMBOURGhistory → | NY REGISTRY SH | 3.50% | $2M | 94.0K |
| 12 | PASSAGE BIO INC | COM | 2.89% | $2M | 1.24M |
| 13 | ATAI LIFE SCIENCES NV | SHS | 1.92% | $1M | 309.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2022 | $0 | 1 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $54M | 15 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $58M | 13 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $82M | 12 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $114M | 15 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $118M | 14 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $120M | 15 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $147M | 16 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $204M | 25 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $100M | 18 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $123M | 19 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $411M | 25 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $631M | 22 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $685M | 25 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.4B | 32 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.6B | 35 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.